Inductive Bio

Inductive Bio is a San Francisco-based AI drug discovery company that provides a human-guided virtual lab platform for accelerating small molecule drug development. Its core product, Compass, enables medicinal chemists to run millions of in-silico experiments to predict how candidate molecules will behave in the human body — covering ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties — before entering the wet lab. The company's Beacon-1 AI models are trained on a pre-competitive consortium of proprietary ADMET datasets from across the pharma and biotech industry, and have won consecutive first-place finishes in the OpenADMET blind prediction competition in 2025 and 2026. Inductive Bio also offers Embedded Experts services and end-to-end chemistry programs in partnership with CROs. The company is backed by Andreessen Horowitz (a16z) and Lux Capital.